Daily Sepsis Research Analysis
Analyzed 53 papers and selected 3 impactful papers.
Summary
Three impactful sepsis studies stood out today: a Texas-wide interrupted time series found sustained increases in sepsis and infection among high-risk pregnant women after SB8; a 2.0-million-patient registry analysis showed that the prognostic value of leukocytosis depends on whether infection is present; and a prospective cohort identified low serum MMP9 at ICU admission as an independent predictor of 28-day mortality in elderly sepsis.
Research Themes
- Policy change and maternal sepsis risk
- Context-aware interpretation of common biomarkers (leukocytosis)
- Early prognostication in elderly sepsis using MMP9
Selected Articles
1. Critical Illness Outcomes of Hospitalized Pregnant Women Following a Texas Abortion Ban.
In a statewide interrupted time series of 2,344,135 hospitalizations, SB8 was not associated with changes in critical illness rates overall. However, among 497,144 high-risk pregnant patients, SB8 was associated with sustained increases per quarter in critical illness, sepsis, and infection, but not mechanical ventilation, with no immediate step changes.
Impact: This large, policy-natural-experiment analysis isolates sustained trends in sepsis and infection among high-risk pregnant inpatients after SB8, informing preparedness and prevention strategies in abortion-restrictive settings.
Clinical Implications: Hospitals in abortion-restrictive states should enhance infection prevention, early sepsis recognition, and critical care training for high-risk pregnant patients, with resource planning aligned to sustained upward trends.
Key Findings
- In the full cohort (n=2,344,135), SB8 was not associated with adjusted rates of critical illness, sepsis, mechanical ventilation, or infection.
- After SB8, the proportion of hospitalized pregnant patients with high-risk features increased over time (sustained slope change 0.92 per 1,000 per quarter).
- In the high-risk subgroup (n=497,144), SB8 was associated with sustained increases per quarter in critical illness (0.17), sepsis (0.15), and infection (1.60) per 1,000 hospitalizations; no change for mechanical ventilation.
Methodological Strengths
- Statewide interrupted time series with very large sample size
- Adjusted analyses with separation of immediate step vs. sustained slope changes and prespecified high-risk subgroup
Limitations
- Reliance on administrative coding for exposures and outcomes limits clinical granularity and causal inference
- Findings may not generalize beyond Texas or to outpatient settings
Future Directions: Replicate in other jurisdictions; link patient-level clinical data to elucidate mechanisms (e.g., delayed care, infection source) and evaluate targeted prevention bundles for high-risk pregnancies.
IMPORTANCE: In September 2021, Texas Senate Bill 8 (SB8) banned abortion after embryonic cardiac activity. OBJECTIVE: To estimate the association of SB8 with critical illness rates. DESIGN: Interrupted time series (ITS). SETTING: Hospitals in Texas. PARTICIPANTS: Retrospective cohort of pregnant women between 10-54 years of age hospitalized between January 2018-March 2024. A subgroup of patients with high-risk features, defined as age < 18 or > 34 years or ≥ 1 chronic illnesses. MEASUREMENTS: The primary outcome was critical illness, defined as sepsis or mechanical vent
2. How infection affects the relationship between leukocyte count and mortality risk in intensive care.
In a 2,016,578-patient registry from 212 ICUs (2010–2023), the mortality association of leukocytosis varied by whether infection was the primary diagnosis. Among non-infective admissions, higher leukocyte counts above a threshold were linked to progressively higher adjusted mortality.
Impact: This study challenges one-size-fits-all use of leukocytosis in ICU risk models, showing its prognostic meaning depends on infection status across a massive multicenter dataset.
Clinical Implications: Interpret leukocyte counts within the infection context when triaging and calibrating ICU prognostic tools; avoid overestimating risk from leukocytosis in patients where it may be adaptive.
Key Findings
- Analysis included 2,016,578 ICU patients across 212 units (2010–2023).
- In non-infective admissions (86.4% of cohort; 115,613 deaths), adjusted odds of mortality rose progressively as leukocyte counts exceeded a threshold.
- The prognostic significance of leukocytosis differed when infection was the primary diagnosis, indicating context-dependent risk.
Methodological Strengths
- Very large, multicenter registry spanning 13 years
- Mixed-effects multivariable modeling to adjust for confounding and site effects
Limitations
- Administrative/registry definitions of infection and timing may introduce misclassification
- Observational design limits causal inference and residual confounding may remain
Future Directions: Recalibrate ICU prognostic models to incorporate infection context; validate thresholds and functional forms (e.g., nonlinear associations) prospectively.
PURPOSE: Leukocyte count is widely available and included in Intensive Care Unit prognostic systems. We hypothesised that the relationship between leukocytosis and mortality risk might differ in critically ill patients admitted with infection, where leukocytosis may be an adaptive response. METHODS: We performed a registry-based study using the Australian and New Zealand Intensive Care Society Adult Patient Database between 2010 and 2023, across 212 Intensive Care Units. Using descriptive statistics and mixed-effects multivariable logistic regression, we evaluated the association between early peak leukocyte count and mortality, according to whether infection was the primary diagnosis. RESULTS: We examined 2,016,578 patients, of whom 1,742,195 had non-infective illnesses (86.4%). In this group, there were 115,613 (6.6%) deaths, and a progressive increase in the adjusted odds of mortality as leukocyte counts increased above 8 × 10 CONCLUSION: The presence of infection determines the prognostic significance of leukocytosis in the critically ill.
3. Prognostic Value of Serum MMP9 in Predicting Mortality Among Elderly Patients with Sepsis: A Prospective Cohort Study.
In 258 elderly ICU patients with sepsis, lower admission MMP9 levels independently predicted higher 28-day mortality. Predictive performance improved substantially when MMP9 was combined with SOFA (AUC up to 0.865).
Impact: Identifies an easily measurable biomarker that, combined with SOFA, enhances early risk stratification in an especially vulnerable sepsis population.
Clinical Implications: Consider measuring MMP9 at ICU admission for elderly sepsis; integrating MMP9 with SOFA could refine triage, monitoring intensity, and goals-of-care discussions.
Key Findings
- Admission MMP9 was significantly lower in non-survivors than survivors.
- MMP9 predicted 28-day mortality with AUC 0.733–0.805 and improved to 0.855–0.865 when combined with SOFA.
- MMP9, SOFA, APACHE II, and lactate were independent predictors in multivariable models.
Methodological Strengths
- Prospective design with separate discovery and validation cohorts
- Biomarker sampling within 24 hours and multivariable/AUC analyses
Limitations
- Single-center design and modest sample size may limit generalizability
- Lack of trial registration and potential spectrum bias in elderly-only cohort
Future Directions: External multicenter validation, assessment of dynamic MMP9 changes, and evaluation of MMP9-guided care pathways on patient-centered outcomes.
BACKGROUND: Sepsis, recognized as a severe syndrome resulting from an uncontrolled inflammatory response, has emerged as a significant public health concern, and it has become a major public health issue, particularly among elderly individuals aged ≥ 65 years. Matrix Metalloproteinase-9 (MMP9), an enzyme belonging to the matrix metalloproteinase family, plays a pivotal role in the progression of various inflammatory and oncological diseases. Nevertheless, the influence of MMP9 on mortality prediction in elderly patients with sepsis remains ambiguous. Consequently, this study aimed to investigate the effect of serum MMP9 on 28-day mortality in elderly sepsis patients admitted to the intensive care unit (ICU). METHODS: A total of 258 eligible elderly sepsis patients were included and divided into a discovery cohort and a validation cohort. Serum MMP9 and other biomarkers, such as interleukin-6 (IL-6) and lactate (LAC), were measured within 24 hours after admission, and clinical data, including 28-day survival status, SOFA scores, and APACHE II scores, were collected. Assessments were conducted using binary logistic regression and AUC analysis. A limitation of this study is the lack of prospective registration in a clinical trial registry. RESULTS: The serum MMP9 levels in non-survivors were significantly lower than those in survivors. The AUC of MMP9 for predicting 28-day mortality ranged from 0.733 to 0.805 and increased to 0.855-0.865 when combined with SOFA scores. Low concentrations of MMP9 were associated with reduced survival rates; MMP9 was negatively correlated with SOFA scores, APACHE II scores, and other biomarkers. MMP9, SOFA scores, APACHE II scores, and LAC were identified as independent predictors. CONCLUSION: Serum MMP9 at ICU admission is a significant predictor of 28-day mortality in elderly sepsis patients, providing references for early clinical treatment decisions.